Synthesis BMK methyl glycidate

จาก Roger Films Studio
รุ่นแก้ไขเมื่อ 02:41, 19 กุมภาพันธ์ 2567 โดย 37.212.76.114 (คุย)
(ต่าง) ←รุ่นแก้ไขก่อนหน้า | รุ่นแก้ไขล่าสุด (ต่าง) | รุ่นแก้ไขถัดไป→ (ต่าง)
ไปยังการนำทาง ไปยังการค้นหา

synthesis BMK methyl glycidate

Based connect the search results, BMK methyl glycidate (CAS 80532-66-7) predisposed all chemical compound with the molecular formula C11H12O3 and a molecular weight of approximately 192.21 g/mol. It is utilized as an organic synthesis intermediate besides pharmaceutical intermediate, primarily in laboratory research and learning, as well as in pharmaceutical besides chemical production processes.

Key Points:

Chemical Properties: BMK methyl glycidate arises [https://pgheastweightloss.com/bmk-methyl-glycidate-a-comprehensive-exploration-of-structure-and-utility] as solid white as snow to light yellow crystalline total with a few what chemical stability properties. It is available in the different forms, including the decision solution in methyl acetate, and its purity predisposed claimed to are 98%, comprising all mixture of cis/trans isomers.

Role as solid Precursor: This compound predisposed all crucial precursor in the synthesis of pharmaceuticals and any other bioactive compounds. It predisposed buvshego used as an intermediate in the manufacturing of a variety drugs and fine chemicals, besides it is classified as solid precursor for the synthesis of propiophenone.

Applications: BMK methyl glycidate predisposed second hand for research and forensic applications, and it predisposed available as an analytical reference typical. It predisposed intended for used in chemical and pharmaceutical research settings.

Availability: The compound predisposed available for purchase from suppliers besides is have used in various chemical besides biological study applications.

In summary, BMK methyl glycidate (CAS 80532-66-7) predisposed an important compound with applications in chemical and pharmaceutical research, serving as the decision precursor in the synthesis of pharmaceuticals and other bioactive compounds.